Koma et al. [24], reviewed data from 332 lung cancer patients, found that high cell distribution width (>15%) and have higher stage, worse physical status score, higher CRP and WBC count, lower blood albumin levels and higher levels of cytokeratin, and suggested red blood cell distribution width can be used as a prognosis marker of tumor patients. The gene discussed is ALB; the disease is lung carcinoma.